Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice

Journal of Applied Physiology

Volumn 109, Issue 3, 2010, Pages 886-894

  Personius, Kirkwood E ^a   Jayaram, Aditi ^a   Krull, David ^b   Brown, Roger ^b   Xu, Tianshun ^b   Han, Bajin ^b   Burgess, Kerri ^c   Storey, Christopher ^c   Shah, Bharati ^c   Tawil, Rabi ^c   Welle, Stephen ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Eccentric contractions; Exercise; Extensor digitorum longus; Muscle hypertrophy

Indexed keywords

CRE RECOMBINASE; INTEGRASE; MSTN PROTEIN, MOUSE; MYOSTATIN;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; C57BL MOUSE; EXERCISE; GENETICS; HYPERTROPHY; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; MOUSE MUTANT; MUSCLE CONTRACTION; MUSCLE STRENGTH; ORGAN SIZE; PATHOLOGY; SKELETAL MUSCLE;

ANIMALS; BEHAVIOR, ANIMAL; HYPERTROPHY; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSTATIN; ORGAN SIZE; PHYSICAL EXERTION;

EID: 77957157930     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00300.2010     Document Type: Article

References (34)

1. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 104:1835-1840, 2007.
2. Baligand C, Gilson H, Menard JC, Schakman O, Wary C, Thissen JP, Carlier PG. Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopy. Gene Ther 17:328-337, 2010.
3. Bigland B, Jehring B. Muscle performance in rats, normal and treated with growth hormone. J Physiol 116:129-136, 1952.
4. Blaauw B, Canato M, Agatea L, Toniolo L, Mammucari C, Masiero E, Abraham R, Sandri M, Schiaffino S, Reggiani C. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J 23:3896-3905, 2009.
5. Byron CD, Borke J, Yu J, Pashley D, Wingard CJ, Hamrick M. Effects of increased muscle mass on mouse sagittal suture morphology and mechanics. Anat Rec A Discov Mol Cell Evol Biol 279:676-684, 2004.
6. Donovan CM, Faulkner JA. Muscle grafts overloaded by ablation of synergistic muscles. J Appl Physiol 61:288-292, 1986.
7. Dumonceaux J, Amthor H. Current advances in the development of therapies for neuromuscular disorders based on myostatin signaling, 3rd International Institute of Myology Workshop, Paris, September 12th, 2008. Neuromuscul Disord 19:797-799, 2009.
8. Duncan ND, Williams DA, Lynch GS. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clin Sci (Lond) 98:339-347, 2000.
9. Fedoruk MN, Rupert JL. Myostatin inhibition: a potential performance enhancement strategy? Scand J Med Sci Sports 18:123-131, 2008.
10. Foster K, Graham IR, Otto A, Foster H, Trollet C, Yaworsky PJ, Walsh FS, Bickham D, Curtin NA, Kawar SL, Patel K, Dickson G. Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle. Rejuvenation Res 12:85-93, 2008.
11. Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow-and fast-type skeletal muscle. Muscle Nerve 31:34-40, 2005.
12. Holmes JH, Ashmore CR, Robinson DW. Effects of stress on cattle with hereditary muscular hypertrophy. J Anim Sci 36:684-694, 1973.
13. Ingalls CP, Barnes WS, Smith SB. Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content. J Appl Physiol 80:795-801, 1996.
14. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, Hamilton JA, Ouchi N, Lebrasseur NK, Walsh K. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7:159-172, 2008.
15. Kambadur R, Sharma M, Smith TPL, Bass JJ. Mutations in myostatin (GDF-8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7:910-915, 1997.
16. Kandarian SC, White TP. Mechanical deficit persists during long-term muscle hypertrophy. J Appl Physiol 69:861-867, 1990.
17. Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PML, Clark KR, Sahenk Z, Mendell JR, Kaspar BK. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med 1:6ra15, 2009.
18. Lebrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 64:940-948, 2009.
19. Matsakas A, Foster K, Otto A, Macharia R, Elashry MI, Feist S, Graham I, Foster H, Yaworsky P, Walsh F, Dickson G, Patel K. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice. Neuromuscul Disord 19:489-499, 2009.
20. McGinnis MY, Lumia AR, Tetel MJ, Molenda-Figueira HA, Possidente B. Effects of anabolic androgenic steroids on the development and expression of running wheel activity and circadian rhythms in male rats. Physiol Behav 92:1010-1018, 2007.
21. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83-90, 1997.
22. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94:12457-12461, 1997.
23. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 101:898-905, 2006.
24. Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, Ostrander EA. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3: e79, 2007.
25. Personius KE, Nautiyal J, Reddy S. Myotonia and muscle contractile properties in mice with SIX5 deficiency. Muscle Nerve 31:503-505, 2005.
26. Personius KE, Sawyer RP. Variability and failure of neurotransmission in the diaphragm of mdx mice. Neuromuscul Disord 16:168-177, 2006.
27. Qiao C, Li J, Jiang J, Zhu X, Wang B, Li J, Xiao X. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 19:241-254, 2008.
28. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39:283-296, 2009.
29. Steelman CA, Recknor JC, Nettleton D, Reecy JM. Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy. FASEB J 20:580-582, 2006.
30. Welle S, Bhatt K, Pinkert CA. Myofibrillar protein synthesis in myostatindeficient mice. Am J Physiol Endocrinol Metab 290:E409-E415, 2006.
31. Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA. Muscle growth after postdevelopmental myostatin gene knockout. Am J Physiol Endocrinol Metab 292: E985-E991, 2007.
32. Welle S, Burgess K, Thornton CA, Tawil R. Relation between extent of myostatin depletion and muscle growth in mature mice. Am J Physiol Endocrinol Metab 297: E935-E940, 2009.
33. Welle S, Cardillo A, Zanche M, Tawil R. Skeletal muscle gene expression after myostatin knockout in mature mice. Physiol Genomics 38:342-350, 2009.
34. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300:965-971, 2003.